The Avita Medical share price just leapt 17%! What's going on?

Avita Medical shares are now up a whopping 110% in 2023.

| More on:
A group of science or medical professionals cheering good news in the lab.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Avita Medical Inc (ASX: AVH) share price is having a banner day.

Shares in the ASX healthcare stock closed yesterday trading for $3.56. In morning trade on Tuesday, shares were swapping hands for $4.16, up a whopping 16.9%.

After what looks to be a bit of profit-taking, shares are currently trading for $4.06 apiece, up 14.04%.

With those gains factored in, the Avita Medical share price is up a stellar 110% in 2023.

For some context, the All Ordinaries Index (ASX: XAO) is up 0.64% today and up 1% year to date.

So, what's stirring investor interest in the regenerative medicine company today?

What's lifting the Avita Medical share price?

With no fresh price-sensitive news out from the ASX healthcare share, the Avita Medical share price looks to be rebounding from its 4% sell-down yesterday and continuing in line with Friday's 16.7% gains.

Friday's gains were spurred by the company's third-quarter update, with investors reacting positively to Avita's commercial revenue growth.

Commercial revenue increased 51% over the three months to reach US$13.5 million.

And investors weren't put off by the 48% increase in operating expenses, which saw Avita's net loss increase 55% to US$8.7 million over the quarter.

Investors may have shrugged off that loss because the company retained just over US$60 million cash on hand, which management said was enough to meet its profitability goals.

Crucially, Avita Medical CEO Jim Corbett anticipates the company will receive US FDA approval for its Recell Go product by mid-2024.

"We expect to submit a response to the FDA's open questions on February 28, 2024," Corbett said.

"Under the Breakthrough Device program, we anticipate FDA approval on May 30, 2024, which positions us for a launch the following day," he added.

That long-awaited FDA approval, should it come through, could offer some sustained tailwinds for the Avita Medical share price.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical. The Motley Fool Australia has recommended Avita Medical. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Person pretends to types on laptop drawn in sand.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a miserly session for investors today.

Read more »

Happy coal miner.
Share Gainers

Up 75% this week, why is this ASX All Ords stock rocketing again today?

Investors are piling into this ASX 300 stock on Wednesday. But why?

Read more »

A young woman smiles as she rides a zip line high above the trees.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a bountiful session for investors this hump day.

Read more »

Man looking happy and excited as he looks at his mobile phone.
Share Gainers

Why Coronado, DroneShield, Lovisa, and Mayne Pharma shares are racing higher today

These shares are having a good time on hump day. But why?

Read more »

Man pointing at a blue rising share price graph.
Share Gainers

Guess which ASX 300 stock just rocketed 43% on big news!

Investors are piling into this ASX 300 stock on Wednesday. But why?

Read more »

Three friends leaping in the air in joy with a dog on the ground.
Share Gainers

Can May's top 3 performing ASX 50 stocks repeat in June?

These three blue chip stocks led the pack in the month of May. Do brokers think they can back it…

Read more »

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX was back to the races this Tuesday.

Read more »

A woman reaches her arms to the sky as a plane flies overhead at sunset.
Travel Shares

Why the Qantas share price soared 20% in May to new all-time highs

With another stellar month in May, Qantas shares are up more than 79% in a year.

Read more »